Affiliation:
1. Russian Medical Academy of Continuous Professional Education
Abstract
Currently, the number of obese people in the world is constantly increasing. Obesity has a direct negative impact on the heart and blood vessels, which can be considered not only as an appropriate response to an increase in the volume of circulating blood due to an increase in body weight, but also as a side tissue reaction of the myocardium to hormonal and metabolic changes inherent in obesity. Our review is devoted to the description of the mechanisms of influence of obesity on the structural and functional parameters of the heart, which create prerequisites for the development of cardiovascular diseases, as well as the existing contradictions. Currently, the accumulated data suggest that an excessive amount of adipose tissue, in addition to metabolic disorders, including insulin resistance, imbalance of adipokines and inflammation markers, leading to the development of lipotoxicity, can directly penetrate the myocardium and cause violations of its contractile properties, as well as affect the conduction of excitation pulses and provoke the development of rhythm and conduction disorders. The development of endothelial dysfunction in obesity ultimately leads to the development of atherosclerosis and coronary heart disease. In addition, obesity contributes to the emergence of risk factors for hypertension, diabetes, atrial fibrillation, chronic heart failure, obstructive sleep apnea syndrome. Given the differences in the literature on the effect of obesity on long-term outcomes in patients with cardiovascular diseases, it is important to conduct prospective studies on the role of individual factors and their combinations that affect the mortality of patients with cardiovascular diseases.
Publisher
Stolichnaya Izdatelskaya Kompaniyaizdat
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Reference73 articles.
1. Obesity and overweight. World health organization. Fact sheet; updated 2018. [cited by Jun 01, 2019]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Diagnosis, treatment, prevention of obesity and its associated diseases (national clinical guidelines, 2017) [cited by Jun 01, 2019]. Available from: https://scardio.ru/content/Guidelines/project/Ozhirenie_klin_rek_proekt.pdf (In Russ.)
3. Drapkina O.M., Dubolazova Y.V., Boytsov S.A. The fight against obesity: the "gold standard" and new horizons. Rational Pharmacotherapy in Cardiology. 2016;12(4):450-8 (In Russ.) DOI: 10.20996/1819-64462016-12-4-450-458.
4. Zhernakova Y.V., Zheleznova E.A., Chazova I.E., et al. The prevalence of abdominal obesity in the subjects of the Russian Federation and its relationship with socio-economic status, the results of an epidemiological study of the ESSE-RF. Ter Arkhiv. 2018;90(10):14-22 (In Russ.) DOI:10.26442/terarkh201890104-22.
5. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89(3):1333-445. DOI:10.1161/01.cir.89.3.1333.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献